Home › Companies › IRadimed Corporation › 2025-2026

IRadimed Corporation 2025-2026 Proxy Voting Records

Compiled from SEC Form N-PX filings and IRadimed Corporation’s Form 8-K, filed 2026-06-24 (Item 5.07 on EDGAR). Page generated 02 October 2026.

  • 8Reported items
  • 278Asset managers
  • 1,866Fund votes
  • 2026-06-23Meeting date

Proxy season: 2023-2024 2024-2025 2025-2026

Explore IRadimed Corporation in the interactive database Compare manager voting policies

Official 2025-2026 meeting results reported by IRadimed Corporation

These tallies are IRadimed Corporation’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2026-06-24 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

IRadimed Corporation — official shareholder meeting results, meeting held 2026-06-23
Ballot itemForAgainst AbstainWithheldBroker non-votesOutcome
Elect Director: Roger Susi 8,638,178---- 1,972,758759,594 Majority: yes
Elect Director: Monty Allen 9,266,549---- 1,344,387759,594 Majority: yes
Elect Director: Joe Kiani 10,492,206---- 118,730759,594 Majority: yes
Elect Director: Hilda Scharen-Guivel 10,409,481---- 201,455759,594 Majority: yes
Elect Director: James Hawkins 8,244,802---- 2,366,134759,594 Majority: yes
Proposal 2: Stockholders ratified the selection of RSM US LLP as Iradimed's independent registered public accounting firm to perform independent audit services for the fiscal year ending December 31, 2026, as set forth below. 11,355,8918,7165,923 ---- Majority: yes
Proposal 3: Stockholders approved an advisory resolution on the compensation of Iradimed's named executive officers. 10,487,387106,03017,519 --759,594 Majority: yes

This meeting is also recorded here as 2026-06-24; both records come from the same filing, so the date should be checked against it.

Source: IRadimed Corporation, Form 8-K, filed with the SEC on 2026-06-24 — read the filing on EDGAR.

How asset managers voted at the IRadimed Corporation 2025-2026 meeting

Each item below shows how the 278 asset managers that disclosed a IRadimed Corporation vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of IRadimed Corporation’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. To approve, on a non-binding advisory basis, a resolution on the fiscal 2025 compensation of the Company's named executive officers.

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

Combines 11 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

FOR 99%
FOR: 10,487,387AGAINST: 106,030

IRadimed Corporation’s own tally for this item (“Proposal 3: Stockholders approved an advisory resolution on the compensation of Iradimed's named executive officers.”): 10,487,387 for, 106,030 against, per its Form 8-K filed 2026-06-24 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 12,783,035 outstanding shares: 82% for, 0.9% against (83% of the company cast a for/against vote).

The 277 asset managers below cast 99% of the shares they voted on this item FOR (6,662,370 for, 97,286 against).

FOR 98%
FOR: 6,662,370 (97.8%)AGAINST: 97,286 (1.4%)ABSTAIN: 52,987 (0.8%)NOT VOTED: 108 (0.0%)
Largest asset managers voting on “To approve, on a non-binding advisory basis, a resolution on the fiscal 2025 compensation of the Company's nam” at IRadimed Corporation, 2025-2026
Asset managerForAgainst AbstainWithheldVote
BlackRock829,7870 00For
Vanguard539,1120 00For
T. Rowe Price438,1790 00For
Fidelity407,2510 00For
Renaissance340,5800 00For
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC336,3390 00For
GEODE CAPITAL MANAGEMENT, LLC290,0750 00For
Nine Ten Capital Management LLC279,0620 00For
Copeland Capital Management, LLC204,6870 00For
State Street186,8690 00For
Virtus149,8080 00For
Goldman Sachs148,7160 00For
Charles Schwab133,7190 00For
Russell Investments126,3710 00For
ACADIAN ASSET MANAGEMENT LLC123,497277 00For
Northern Trust121,1600 00For
Jackson National98,5510 00For
STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM95,4230 00For
Nuveen88,5810 00For
TIAA84,7920 00For
Dimensional80,2460 00For
First Trust76,5210 00For
Two Sigma67,8980 00For
Ranger Investment Management, L.P.57,8450 00For
Victory Capital52,1640 00For

Showing the 25 largest of 277 asset managers. See all 277 in the interactive database.

2. Election of Directors: Hilda Scharen-Guivel

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 7 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 10,409,481WITHHELD: 201,455

IRadimed Corporation’s own tally for this item (“Elect Director: Hilda Scharen-Guivel”): 10,409,481 for, 201,455 withheld, per its Form 8-K filed 2026-06-24 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 12,783,035 outstanding shares: 81% for, 2% withheld (83% of the company cast a for/withheld vote).

The 77 asset managers below cast 100% of the shares they voted on this item FOR (2,307,082 for, 0 against).

FOR 96%
FOR: 2,307,082 (96.3%)ABSTAIN: 88,706 (3.7%)
Largest asset managers voting on “Election of Directors: Hilda Scharen-Guivel” at IRadimed Corporation, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard470,3620 00For
BlackRock423,1790 00For
Fidelity336,0410 00For
T. Rowe Price167,5850 00For
Virtus149,8080 00For
Jackson National98,5510 00For
TIAA00 84,7920Abstain
First Trust76,3550 00For
Charles Schwab66,7830 00For
Dimensional51,6780 00For
Goldman Sachs51,1080 00For
Russell Investments45,9050 00For
Calamos43,4310 00For
WisdomTree36,3360 00For
Victory Capital26,0820 00For
American Century22,2040 00For
State Street20,2970 00For
Equitable18,9280 00For
AllianceBernstein14,9890 00For
QUANTITATIVE MASTER SERIES LLC12,7910 00For
RMB INVESTORS TRUST12,3210 00For
Lincoln Financial11,4280 00For
MASTER INVESTMENT PORTFOLIO10,4480 00For
Voya10,2070 00For
Nationwide9,4520 00For

Showing the 25 largest of 77 asset managers. See all 77 in the interactive database.

3. Election of Directors: James Hawkins

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 7 wordings of this item as funds reported it.

78% Majority: yes · of votes cast

FOR 78%WITHHELD 22%
FOR: 8,244,802WITHHELD: 2,366,134

IRadimed Corporation’s own tally for this item (“Elect Director: James Hawkins”): 8,244,802 for, 2,366,134 withheld, per its Form 8-K filed 2026-06-24 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 12,783,035 outstanding shares: 64% for, 19% withheld (83% of the company cast a for/withheld vote).

The 77 asset managers below cast 100% of the shares they voted on this item FOR (1,676,579 for, 0 against).

FOR 70%ABSTAIN 30%
FOR: 1,676,579 (70.0%)ABSTAIN: 719,206 (30.0%)
Largest asset managers voting on “Election of Directors: James Hawkins” at IRadimed Corporation, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard469,9610 3980For
BlackRock423,1790 00For
Fidelity75,8680 260,1730Abstain
T. Rowe Price167,5850 00For
Virtus147,2870 2,5210For
Jackson National95,6830 2,8680For
TIAA00 84,7920Abstain
First Trust00 76,3550Abstain
Charles Schwab00 66,7830Abstain
Dimensional00 51,6780Abstain
Goldman Sachs51,1080 00For
Russell Investments00 45,9050Abstain
Calamos43,4310 00For
WisdomTree36,3360 00For
Victory Capital00 26,0820Abstain
American Century22,2040 00For
State Street20,2540 430For
Equitable18,9280 00For
AllianceBernstein14,9890 00For
QUANTITATIVE MASTER SERIES LLC12,7910 00For
RMB INVESTORS TRUST00 12,3210Abstain
Lincoln Financial5,6000 5,8280Abstain
MASTER INVESTMENT PORTFOLIO10,4480 00For
Voya10,2070 00For
Nationwide8,8780 5740For

Showing the 25 largest of 77 asset managers. See all 77 in the interactive database.

4. Election of Directors: Joe Kiani

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 7 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

FOR 99%
FOR: 10,492,206WITHHELD: 118,730

IRadimed Corporation’s own tally for this item (“Elect Director: Joe Kiani”): 10,492,206 for, 118,730 withheld, per its Form 8-K filed 2026-06-24 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 12,783,035 outstanding shares: 82% for, 1.0% withheld (83% of the company cast a for/withheld vote).

The 77 asset managers below cast 100% of the shares they voted on this item FOR (2,390,878 for, 0 against).

FOR 99.7%
FOR: 2,390,878 (99.8%)ABSTAIN: 4,910 (0.2%)
Largest asset managers voting on “Election of Directors: Joe Kiani” at IRadimed Corporation, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard470,3620 00For
BlackRock423,1790 00For
Fidelity336,0410 00For
T. Rowe Price166,5890 9960For
Virtus149,8080 00For
Jackson National98,5510 00For
TIAA84,7920 00For
First Trust76,3550 00For
Charles Schwab66,7830 00For
Dimensional51,6780 00For
Goldman Sachs51,1080 00For
Russell Investments45,9050 00For
Calamos43,4310 00For
WisdomTree36,3360 00For
Victory Capital26,0820 00For
American Century22,2040 00For
State Street20,2970 00For
Equitable18,9280 00For
AllianceBernstein14,9890 00For
QUANTITATIVE MASTER SERIES LLC12,7910 00For
RMB INVESTORS TRUST12,3210 00For
Lincoln Financial11,4280 00For
MASTER INVESTMENT PORTFOLIO10,4480 00For
Voya10,2070 00For
Nationwide9,4520 00For

Showing the 25 largest of 77 asset managers. See all 77 in the interactive database.

5. Election of Directors: Monty Allen

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 7 wordings of this item as funds reported it.

87% Majority: yes · of votes cast

FOR 87%13%
FOR: 9,266,549WITHHELD: 1,344,387

IRadimed Corporation’s own tally for this item (“Elect Director: Monty Allen”): 9,266,549 for, 1,344,387 withheld, per its Form 8-K filed 2026-06-24 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 12,783,035 outstanding shares: 72% for, 11% withheld (83% of the company cast a for/withheld vote).

The 77 asset managers below cast 100% of the shares they voted on this item FOR (1,770,808 for, 0 against).

FOR 74%ABSTAIN 26%
FOR: 1,770,808 (73.9%)ABSTAIN: 624,980 (26.1%)
Largest asset managers voting on “Election of Directors: Monty Allen” at IRadimed Corporation, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard469,9690 3930For
BlackRock00 423,1790Abstain
Fidelity330,3970 5,6440For
T. Rowe Price167,5850 00For
Virtus149,8080 00For
Jackson National98,5510 00For
TIAA00 84,7920Abstain
First Trust76,3550 00For
Charles Schwab66,7830 00For
Dimensional51,6780 00For
Goldman Sachs51,1080 00For
Russell Investments00 45,9050Abstain
Calamos43,4310 00For
WisdomTree36,3360 00For
Victory Capital26,0820 00For
American Century22,2040 00For
State Street20,2960 10For
Equitable5,9800 12,9480Abstain
AllianceBernstein14,9890 00For
QUANTITATIVE MASTER SERIES LLC00 12,7910Abstain
RMB INVESTORS TRUST12,3210 00For
Lincoln Financial11,4280 00For
MASTER INVESTMENT PORTFOLIO00 10,4480Abstain
Voya10,2070 00For
Nationwide7,2140 2,2380For

Showing the 25 largest of 77 asset managers. See all 77 in the interactive database.

6. Election of Directors: Roger Susi

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 7 wordings of this item as funds reported it.

81% Majority: yes · of votes cast

FOR 81%WITHHELD 19%
FOR: 8,638,178WITHHELD: 1,972,758

IRadimed Corporation’s own tally for this item (“Elect Director: Roger Susi”): 8,638,178 for, 1,972,758 withheld, per its Form 8-K filed 2026-06-24 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 12,783,035 outstanding shares: 68% for, 15% withheld (83% of the company cast a for/withheld vote).

The 76 asset managers below cast 100% of the shares they voted on this item FOR (1,887,228 for, 0 against).

FOR 79%ABSTAIN 21%
FOR: 1,887,228 (78.9%)ABSTAIN: 504,629 (21.1%)
Largest asset managers voting on “Election of Directors: Roger Susi” at IRadimed Corporation, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard470,3550 70For
BlackRock423,1790 00For
Fidelity75,8680 260,1730Abstain
T. Rowe Price167,5850 00For
Virtus147,2870 2,5210For
Jackson National95,6830 2,8680For
TIAA84,7920 00For
First Trust00 76,3550Abstain
Charles Schwab66,7830 00For
Dimensional00 51,6780Abstain
Goldman Sachs51,1080 00For
Russell Investments45,9050 00For
Calamos43,4310 00For
WisdomTree36,3360 00For
Victory Capital00 26,0820Abstain
American Century22,2040 00For
State Street20,2610 360For
Equitable18,9280 00For
AllianceBernstein14,9890 00For
QUANTITATIVE MASTER SERIES LLC12,7910 00For
RMB INVESTORS TRUST00 12,3210Abstain
Lincoln Financial5,6000 5,8280Abstain
MASTER INVESTMENT PORTFOLIO10,4480 00For
Voya00 10,2070Abstain
Nationwide9,4520 00For

Showing the 25 largest of 76 asset managers. See all 76 in the interactive database.

7. To ratify the appointment of RSM US LLP as the independent registered public accounting firm of the Company for the year ending December 31, 2026; and

AUDIT-RELATEDMajority of the votes cast: yes

Combines 3 wordings of this item as funds reported it.

99.9% Majority: yes · of votes cast

FOR 99.9%
FOR: 11,355,891AGAINST: 8,716

IRadimed Corporation’s own tally for this item (“Proposal 2: Stockholders ratified the selection of RSM US LLP as Iradimed's independent registered public accounting firm to perform independent audit services for the fiscal year ending December 31, 2026, as set forth b”): 11,355,891 for, 8,716 against, per its Form 8-K filed 2026-06-24 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 12,783,035 outstanding shares: 89% for, 0.1% against (89% of the company cast a for/against vote).

The 76 asset managers below cast 99.9% of the shares they voted on this item FOR (2,389,622 for, 1 against).

FOR 99.8%
FOR: 2,389,622 (99.8%)AGAINST: 1 (0.0%)ABSTAIN: 3,914 (0.2%)
Largest asset managers voting on “To ratify the appointment of RSM US LLP as the independent registered public accounting firm of the Company fo” at IRadimed Corporation, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard470,3620 00For
BlackRock423,1790 00For
Fidelity336,0410 00For
T. Rowe Price167,5850 00For
Virtus149,8080 00For
Jackson National98,5510 00For
TIAA84,7920 00For
First Trust76,3550 00For
Charles Schwab66,7830 00For
Dimensional51,6780 00For
Goldman Sachs51,1080 00For
Russell Investments45,9050 00For
Calamos43,4310 00For
WisdomTree36,3360 00For
Victory Capital26,0820 00For
American Century22,2040 00For
State Street20,2961 00For
Equitable18,9280 00For
AllianceBernstein14,9890 00For
QUANTITATIVE MASTER SERIES LLC12,7910 00For
RMB INVESTORS TRUST12,3210 00For
Lincoln Financial11,4280 00For
MASTER INVESTMENT PORTFOLIO10,4480 00For
Voya10,2070 00For
Nationwide9,4520 00For

Showing the 25 largest of 76 asset managers. See all 76 in the interactive database.

8. Ratify Appointment of Independent Auditors

AUDIT-RELATEDMajority of the votes cast: yes

99.9% Majority: yes · of votes cast

FOR 99.9%
FOR: 11,355,891AGAINST: 8,716

IRadimed Corporation’s own tally for this item (“Proposal 2: Stockholders ratified the selection of RSM US LLP as Iradimed's independent registered public accounting firm to perform independent audit services for the fiscal year ending December 31, 2026, as set forth b”): 11,355,891 for, 8,716 against, per its Form 8-K filed 2026-06-24 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 12,783,035 outstanding shares: 89% for, 0.1% against (89% of the company cast a for/against vote).

The 2 asset managers below cast 100% of the shares they voted on this item FOR (8,050 for, 0 against).

FOR 100%
FOR: 8,050 (100.0%)
Largest asset managers voting on “Ratify Appointment of Independent Auditors” at IRadimed Corporation, 2025-2026
Asset managerForAgainst AbstainWithheldVote
FORUM FUNDS II5,8000 00For
AMERICAN PENSION INVESTORS TRUST2,2500 00For

Largest IRadimed Corporation shareholders voting in 2025-2026

Ranked by the number of IRadimed Corporation shares each manager voted on the most widely held ballot item of the 2025-2026 meeting, shown as a share of the 12,783,035 shares outstanding at the time of that meeting.

Top IRadimed Corporation shareholders by shares voted, 2025-2026
#Asset manager % of shares outstanding
1BlackRock 6.49%
2Vanguard 4.22%
3T. Rowe Price 3.43%
4Fidelity 3.19%
5Renaissance 2.66%
6KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC 2.63%
7GEODE CAPITAL MANAGEMENT, LLC 2.27%
8Nine Ten Capital Management LLC 2.18%
9Copeland Capital Management, LLC 1.60%
10State Street 1.46%

Reported IRadimed Corporation ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

IRadimed Corporation beneficial owners on record for the 2025-2026 proxy season
Holder % outstanding Disclosure
Roger E. Susi 34.82% 13G
Roger Susi 34.64% DEF14A
BlackRock 7.57% 13F
Vanguard Group 4.38% 13F
Renaissance Technologies 3.45% 13F
Geode Capital 2.24% 13F
Dimensional Fund Advisors 1.77% 13F
State Street 1.60% 13F
Goldman Sachs 1.55% 13F
Two Sigma 1.30% 13F

Percentages above are of 12,783,035 shares outstanding, as reported by IRadimed Corporation on its Form 10-Q dated 2026-04-30 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from IRadimed Corporation’s 10-Q dated 2026-04-30. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.

At IRadimed Corporation's shareholder meeting held 2026-06-23, in the 2025-2026 proxy season, 278 asset managers reported how they voted in their SEC Form N-PX filings, covering 1,866 separate fund positions. Their filings are grouped here into 8 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — To approve, on a non-binding advisory basis, a resolution on the fiscal 2025 compensation of… — FOR was 99% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: IRadimed Corporation's Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2026-06-24.

IRadimed Corporation proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).